col blocks we are bridge builder col blocks
COVID Antworten in den wissenschaftlichen Zeitschriften der Welt


4 Ergebisse       Seite 1

 [1] 
Elsevier: European Journal of Pharmaceutics and Biopharmaceutics
  Original Artikel Datum Titel Autoren   Alle Autoren
1 [GO] 2024―Okt―24 Exploring yeast glucans for vaccine enhancement: Sustainable strategies for overcoming adjuvant challenges in a SARS-CoV-2 model João Azevedo-Silva, Manuela Amorim, Diana Tavares-Valente, Pedro Sousa, Randolph Mohamath, Emily A. Voigt, et al. (+8)
2 [GO] 2024―Okt―09 Fluoroamphiphiles for enhancing immune response of subunit vaccine against SARS-CoV-2 Yuan Li, Ziyao Kang, Xuefeng Zhang, Yun Sun, Zibo Han, Hao Zhang, et al. (+4)
3 [GO] 2023―Sep―27 Immunogenicity of a silica nanoparticle-based SARS-CoV-2 vaccine in mice Clara Barbey, Jinpeng Su, Martina Billmeier, Nadine Stefan, Romina Bester, George Carnell, et al. (+6)
4 [GO] 2022―Mai―17 RBD decorated PLA nanoparticle admixture with aluminum hydroxide elicit robust and long lasting immune response against SARS-CoV-2 Jairam Meena, Priyank Singhvi, Sudeepa Srichandan, Jyotsna Dandotiya, Juhi Verma, Rahul Ahuja, et al. (+7)
 [1] 

4 Ergebisse       Seite 1



[de][en]

Letzte Änderung 2025―Jul―29 14:55:09 UTC

© Daten-Quadrat 2022       Done in 0.004 sec